Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Circulation. Heart Failure|May 16, 2023
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart StudyNicolas Girerd, Daniel Levy, Kevin Duarte, et al.Journal of the American College of Cardiology|March 26, 2025
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA TrialDavid J Maron, Jonathan D Newman, Rebecca Anthopolos, et al.The New England Journal of Medicine|August 29, 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M Ridker, Brendan M Everett, Tom Thuren, et al.Human Molecular Genetics|February 20, 2010
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levelsMaja Barbalic, Josée Dupuis, Abbas Dehghan, et al.Nature|April 12, 2023
Clonal haematopoiesis and risk of chronic liver diseaseWaihay J Wong, Connor Emdin, Alexander G Bick, et al.Open Heart|August 30, 2023
Ancestral diversity in lipoprotein(a) studies helps address evidence gapsMoa P Lee, Sofia F Dimos, Laura M Raffield, et al.Science Advances|June 26, 2026
Plasma GDF15 affects long-term dementia risk and alters neuroimmune signalingCassandra O Blew, Michael R Duggan, Dimitrios Tsitsipatis, et al.The Lancet. Diabetes & Endocrinology|September 8, 2016
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysisNatriuretic Peptides Studies Collaboration, Peter Willeit, Stephen Kaptoge, et al.Medrxiv : the Preprint Server for Health Sciences|July 30, 2025
Plasma GDF15 affects long-term dementia risk and alters neuro-immune signalingCassandra O Blew, Michael R Duggan, Dimitrios Tsitsipatis, et al.Circulation|October 8, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IMorteza Naghavi, Peter Libby, Erling Falk, et al.Pageof 8